228 related articles for article (PubMed ID: 30159415)
1. Non-coding RNAs in skin cancers: An update.
Kaushik SB; Kaushik N
Noncoding RNA Res; 2016 Oct; 1(1):83-86. PubMed ID: 30159415
[TBL] [Abstract][Full Text] [Related]
2. Non-coding RNA dysregulation in skin cancers.
Durante G; Comito F; Lambertini M; Broseghini E; Dika E; Ferracin M
Essays Biochem; 2021 Oct; 65(4):641-655. PubMed ID: 34414406
[TBL] [Abstract][Full Text] [Related]
3. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
[TBL] [Abstract][Full Text] [Related]
4. Non-coding RNAs in skin cancers:Biological roles and molecular mechanisms.
Liu F; Li S
Front Pharmacol; 2022; 13():934396. PubMed ID: 36034860
[TBL] [Abstract][Full Text] [Related]
5. The Current State of Research Regarding the Role of Non-Coding RNAs in Cutaneous Squamous Cell Carcinoma.
Chen S; Luo L; Chen H; He C
Onco Targets Ther; 2020; 13():13151-13158. PubMed ID: 33380805
[TBL] [Abstract][Full Text] [Related]
6. Non-melanoma skin cancer: new and future synthetic drug treatments.
Amaral T; Garbe C
Expert Opin Pharmacother; 2017 May; 18(7):689-699. PubMed ID: 28414587
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNAs in cutaneous melanoma: clinical perspectives.
Hulstaert E; Brochez L; Volders PJ; Vandesompele J; Mestdagh P
Oncotarget; 2017 Jun; 8(26):43470-43480. PubMed ID: 28415644
[TBL] [Abstract][Full Text] [Related]
9. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
10. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNAs as Potential Diagnostic and Prognostic Biomarkers in Breast Cancer: Progress and Prospects.
Lu C; Wei D; Zhang Y; Wang P; Zhang W
Front Oncol; 2021; 11():710538. PubMed ID: 34527584
[TBL] [Abstract][Full Text] [Related]
12. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring.
Kunej T; Obsteter J; Pogacar Z; Horvat S; Calin GA
Crit Rev Clin Lab Sci; 2014 Dec; 51(6):344-57. PubMed ID: 25123609
[TBL] [Abstract][Full Text] [Related]
13. SPRY4-IT1: A novel oncogenic long non-coding RNA in human cancers.
Li J; Chen Y; Chen Z; He A; Xie H; Zhang Q; Cai Z; Liu Y; Huang W
Tumour Biol; 2017 Jun; 39(6):1010428317711406. PubMed ID: 28651500
[TBL] [Abstract][Full Text] [Related]
14. The Function and Mechanism of Long Non-coding RNA-ATB in Cancers.
Xiao H; Zhang F; Zou Y; Li J; Liu Y; Huang W
Front Physiol; 2018; 9():321. PubMed ID: 29692736
[TBL] [Abstract][Full Text] [Related]
15. Role of COX-2 activity and CRP levels in patients with non-melanoma skin cancer. -765G>C PTGS2 polymorphism and NMSC risk.
Cocoş R; Schipor S; Nicolae I; Thomescu C; Raicu F
Arch Dermatol Res; 2012 Jul; 304(5):335-42. PubMed ID: 22159575
[TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of glioma-associated oncogene homolog 1 in non melanoma skin cancer.
Bakry OA; Samaka RM; Shoeib MA; Megahed DM
Ultrastruct Pathol; 2015 Apr; 39(2):135-46. PubMed ID: 25350271
[TBL] [Abstract][Full Text] [Related]
17. miRNAs in the Diagnosis and Prognosis of Skin Cancer.
Neagu M; Constantin C; Cretoiu SM; Zurac S
Front Cell Dev Biol; 2020; 8():71. PubMed ID: 32185171
[TBL] [Abstract][Full Text] [Related]
18. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
Nguyen AH; Detty SQ; Agrawal DK
Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
[TBL] [Abstract][Full Text] [Related]
19. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
[TBL] [Abstract][Full Text] [Related]
20. Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy.
Han Li C; Chen Y
Curr Genomics; 2015 Oct; 16(5):319-26. PubMed ID: 27047252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]